Methods for treating neuroblastoma with combination therapy
AssigneeMemorial Sloan Kettering Cancer Center
InventorShakeel MODAK
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating neuroblastoma using an anti-GD2 antibody, at least one chemotherapeutic agent, and at least one hematopoietic growth factor. The present disclosure also provides compositions for treating neuroblastoma.
Claims20
A method of treating neuroblastoma in a subject, comprising administering to the subject an anti-GD2 antibody or an antigen-binding fragment thereof, at least one hematopoietic growth factor, and at least one chemotherapeutic agent.
A composition comprising an anti-GD2 antibody or an antigen-binding fragment thereof, at least one hematopoietic growth factor, and at least one chemotherapeutic agent.
Dependencies are inferred from the claim text.